Diagnostic and Interventional Cardiology

Prespecified meta-analysis of DELIVER and EMPEROR-Preserved presented in a Hot Line Session at ESC Congress 2022

News | Pharmaceuticals

Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure

September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and ...

September 06, 2022

Stopping statin treatment early could substantially reduce lifetime protection against heart disease since a large share of the benefit occurs later in life

News | Pharmaceuticals

Study Highlights Lifelong Benefits of Statin Therapy

September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...

September 06, 2022

Smokers have weaker hearts than non-smokers, according to research

News | Stroke

Smoking is Even More Damaging to the Heart Than Previously Thought

September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...

September 06, 2022

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.

News | Stroke

Air Pollution is Associated with Heart Attacks in Non-Smokers

September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...

September 06, 2022

BOX trial presented in a Hot Line Session at ESC Congress 2022

News | Sudden Cardiac Arrest

Restrictive Oxygenation in Post Cardiac Arrest Patients is Not Harmful

September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...

September 02, 2022

DELIVER trial presented in a Hot Line Session at ESC Congress 2022

News | Heart Failure

Dapagliflozin Benefits Patients with Mildly Reduced and Preserved Ejection Fraction

September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...

September 02, 2022

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

ADVOR trial presented in a Hot Line Session at ESC Congress 2022

News | Heart Failure

Acetazolamide Improves Decongestion in Patients with Acute Decompensated Heart Failure

September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...

September 02, 2022

DANCAVAS trial presented in a Hot Line Session at ESC Congress 2022

News | Cardiac Imaging

Cardiovascular Screening May Reduce Risk of Death and Cardiovascular Disease

September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...

September 02, 2022

DANFLU-1 trial presented in a Hot Line Session at ESC Congress 2022

News | Cardiac Imaging

Innovative Randomized Trial Hints at Mortality Benefits with High-Dose Influenza Vaccines

September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...

September 02, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

News | Artificial Intelligence

Artificial Intelligence Assessment of Heart Function is Superior to Sonographer Assessment

September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by ...

September 02, 2022

REVIVED-BCIS2 trial presented in a Hot Line Session today at ESC Congress 2022

News | Heart Failure

Coronary Stenting Does Not Benefit Patients with Severe Left Ventricular Dysfunction

September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ...

September 02, 2022

More than 30,271 health professionals from 174 countries attended this year’s event, which covered the entire field of cardiovascular medicine at ESC22

News | ESC

Best of ESC Congress 2022

September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...

September 01, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Comatose patients admitted to hospital after resuscitation from out-of-hospital cardiac arrest have a significant risk of death and poor neurological outcome due to hypoxic brain injury.

News | Sudden Cardiac Arrest

Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients

September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...

September 01, 2022

ALL-HEART trial presented in a Hot Line Session at ESC Congress 2022

News | Stroke

Allopurinol Does Not Improve Cardiovascular Outcomes in Ischaemic Heart Disease Patients

September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...

September 01, 2022

BioIntelliSense's new BioButton for 90-days of continuous wireless temperature and vital signs monitoring on a coin-sized disposable medical device

News | Wearables

Medtronic Announces Partnership with BioIntelliSense for Exclusive U.S. Distribution of Multi-Parameter Wearable for Continuous Remote Patient Monitoring from in-Hospital to Home

August 31, 2022 — Medtronic plc, a global leader in healthcare technology, announced it has entered into a strategic ...

August 31, 2022